Journal of Attention Disorders

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Free Access - Register Here

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faraone, S.V.
Right arrow Articles by Biederman, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Faraone, S.V.
Right arrow Articles by Biederman, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Attention Disorders, Vol. 6, No. 2, 69-75 (2002)
DOI: 10.1177/108705470200600203

Efficacy of Adderall® for Attention-Deficit/Hyperactivity Disorder: A meta-analysis

S.V. Faraone

J. Biederman

Stimulant medication has, for many years, been the pharmacological treatment of choice for children and adults with Attention- Deficit/Hyperactivity Disorder (ADHD). Several studies have shown Adderall®, to be efficacious for measures of inattention, hyperactivity-impulsivity, aggression, disruptive behavior, and academic productivity. Although these studies provide useful information for clinicians treating ADHD children and adults, the variability in efficacy among the different types of measures used within each study has not been comprehensively examined.

Thus, to provide a clearer picture of what conclusions can be drawn from these studies, we performed a meta-analysis. Data from the six available studies of standard release Adderall® show it to be efficacious for symptoms of inattention, hyperactivity- impulsivity, and aggression, as well as global ratings. Its efficacy was significant for clinician, parent, and teacher ratings, and for both fixed- and best-dose designs.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Adv. Psychiatr. Treat.Home page
A. James
Pharmacotherapy and child psychiatry: is there a way forward?: INVITED COMMENTARY ON... CHILD PSYCHIATRY AND ITS RELATIONSHIP WITH THE PHARMACEUTICAL INDUSTRY
Advan. Psychiatr. Treat., January 1, 2008; 14(1): 10 - 16.
[Abstract] [Full Text] [PDF]

Home page
 J Atten DisordHome page
A. Majewicz-Hefley and J. S. Carlson
A Meta-Analysis of Combined Treatments for Children Diagnosed With ADHD
J Atten Disord, February 1, 2007; 10(3): 239 - 250.
[Abstract] [PDF]

Home page
 Research on Social Work PracticeHome page
J. Corcoran and P. Dattalo
Parent Involvement in Treatment for ADHD: A Meta-Analysis of the Published Studies
Research on Social Work Practice, November 1, 2006; 16(6): 561 - 570.
[Abstract] [PDF]